Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Lenalidomide Capsules

Approval Number

国药准字H20233668

Company四川美大康华康药业有限公司

Registration Date

July 18, 2023

Drug Information

Generic Name

来那度胺胶囊

Dosage Form

胶囊剂

Strength

25mg

Drug Type

化学药品

Registration Date

July 18, 2023

Company Information

Applicant Company

Company Name四川美大康华康药业有限公司

Company Address

四川绵竹经济开发区江苏工业园镇江路1号

Manufacturing Company

Company Name四川美大康华康药业有限公司

Company Address

四川绵竹经济开发区江苏工业园镇江路1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

来那度胺胶囊 - NMPA 批准文号 | MedPath